Thanks to state funding and the expansion of screening programs, cases of breast cancer detected at stage 4 (advanced) in Armenia have decreased from 40% in 2018 to 13% by 2025-2026.
By the numbers
>1600 — the number of new cases recorded annually in Armenia.
~30% — the percentage of women responding to invitations for screening tests (most still miss the opportunity for early detection).
1500 women — have benefited from expensive targeted medications provided by the state (“Trastuzumab”) since 2020.
up to 1.2 million drams — annual medication provision for patients in the metastatic stage under universal insurance by 2026.
50% co-payment — the state's share compared to previously fully paid (~500,000 drams) PET scans and radiosurgery.
Why is this important A radical change in the financial accessibility of treatment allows for the prevention of disease complications and ensures early recovery.
What is now free or subsidized
Completely free. Surgeries, 24 sessions of radiation therapy, targeted medications (“Trastuzumab”), and screenings.
Free mammography. Women aged 45-68 can self-register at their preferred clinic through the ARMED system (without a referral from a family doctor). 10 new mammography machines have been installed in the regions.
State 50% co-payment. PET scans (positron emission tomography) and radiosurgery.
